Global X Genomics & Biotechnology ETF (GNOM)
NASDAQ: GNOM · Real-Time Price · USD
42.53
-0.24 (-0.57%)
At close: Mar 24, 2026, 4:00 PM EDT
42.43
-0.10 (-0.24%)
After-hours: Mar 24, 2026, 4:43 PM EDT
GNOM Holdings Information
GNOM is an equity ETF with a total of 50 individual holdings. The top holdings are Moderna stock at 8.79%, Praxis Precision Medicines at 6.44%, Arrowhead Pharmaceuticals at 5.91%, Illumina at 5.53%, and Guardant Health at 4.98%.
Total Holdings
50
Top 10 Percentage
52.12%
Asset Class
Equity
ETF Category
Health
Assets
49.03M
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | MRNA | Moderna, Inc. | 8.79% |
| 2 | PRAX | Praxis Precision Medicines, Inc. | 6.44% |
| 3 | ARWR | Arrowhead Pharmaceuticals, Inc. | 5.91% |
| 4 | ILMN | Illumina, Inc. | 5.53% |
| 5 | GH | Guardant Health, Inc. | 4.98% |
| 6 | VRTX | Vertex Pharmaceuticals Incorporated | 4.60% |
| 7 | BMRN | BioMarin Pharmaceutical Inc. | 4.41% |
| 8 | NTRA | Natera, Inc. | 4.28% |
| 9 | BNTX | BioNTech SE | 3.65% |
| 10 | TECH | Bio-Techne Corporation | 3.51% |
| 11 | QGEN | Qiagen N.V. | 3.40% |
| 12 | CRSP | CRISPR Therapeutics AG | 3.12% |
| 13 | BMY | Bristol-Myers Squibb Company | 2.85% |
| 14 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.74% |
| 15 | GILD | Gilead Sciences, Inc. | 2.45% |
| 16 | VCYT | Veracyte, Inc. | 2.43% |
| 17 | TWST | Twist Bioscience Corporation | 2.40% |
| 18 | LLY | Eli Lilly and Company | 2.36% |
| 19 | LON: AZN | AstraZeneca PLC | 2.35% |
| 20 | LEGN | Legend Biotech Corporation | 2.29% |
| 21 | BEAM | Beam Therapeutics Inc. | 2.23% |
| 22 | TXG | 10x Genomics, Inc. | 2.01% |
| 23 | RARE | Ultragenyx Pharmaceutical Inc. | 1.77% |
| 24 | WGS | GeneDx Holdings Corp. | 1.75% |
| 25 | HKG: 1548 | Genscript Biotech Corporation | 1.57% |
As of Mar 20, 2026